Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

O -GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation
Qiang Zhu, Hongxing Wang, Siyuan Chai, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 13
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

O-GlcNAcylation in cancer development and immunotherapy
Xue-Fen He, Xiaoli Hu, Gao-Jing Wen, et al.
Cancer Letters (2023) Vol. 566, pp. 216258-216258
Closed Access | Times Cited: 41
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
Hyun Jung Hwang, Donghee Kang, Jisoo Shin, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1
Yizeng Fan, Weichao Dan, Yuzhao Wang, et al.
Cell Metabolism (2025)
Open Access | Times Cited: 2
On a sugar high: Role of O-GlcNAcylation in cancer
Giang Lê Minh, Emily M. Esquea, Riley G. Young, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105344-105344
Open Access | Times Cited: 32
Emerging roles of O-GlcNAcylation in protein trafficking and secretion
Jianchao Zhang, Yanzhuang Wang
Journal of Biological Chemistry (2024) Vol. 300, Iss. 3, pp. 105677-105677
Open Access | Times Cited: 12
Targeting O-GlcNAcylation in cancer therapeutic resistance: The sugar Saga continues
Lulu Chen, Mengxue Hu, Luojun Chen, et al.
Cancer Letters (2024) Vol. 588, pp. 216742-216742
Closed Access | Times Cited: 11
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer
Yi Zhang, Shuyan Zhou, Yan Kai, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Altered glycosylation in cancer: molecular functions and therapeutic potential
Xuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Cancer Communications (2024) Vol. 44, Iss. 11, pp. 1316-1336
Open Access | Times Cited: 7
Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy
Zhuang Zhu, Shaoming Li, Xiaopeng Yin, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130351-130351
Closed Access | Times Cited: 6
Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy
Xueting Ren, Shuai Lin, Feng Guan, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 7, pp. 2607-2621
Open Access | Times Cited: 6
The OGT–c-Myc–PDK2 axis rewires the TCA cycle and promotes colorectal tumor growth
Huijuan Wang, Jie Sun, Haofan Sun, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 9, pp. 1157-1169
Open Access | Times Cited: 5
Cancer stem cell-derived exosomes in CD8+ T cell exhaustion
Amir Gholami
International Immunopharmacology (2024) Vol. 137, pp. 112509-112509
Closed Access | Times Cited: 5
N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment
Zhiyun Duan, Runhan Shi, Bo Gao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
O-GlcNAcylation in tumorigenesis and its implications for cancer therapy
Dize Zhang, Yihang Qi, Hiroyuki Inuzuka, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 9, pp. 107709-107709
Open Access | Times Cited: 5
RNA N4‐acetylcytidine modification and its role in health and diseases
Qiang Wang, Yixiao Yuan, Qiang Zhou, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Bioinformation study of immune microenvironment characteristics of disulfidptosis-related subtypes in ovarian cancer and prognostic model construction
Ying Zhou, Y Zhang, Yang Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Progress in understanding the regulatory mechanisms of immune checkpoint proteins PD-1 and PD-L1 expression
Xuanxuan Wu, Zengjun Zhu, Jian Zhang, et al.
Clinical & Translational Oncology (2025)
Closed Access
Proximity Labeling-Based Identification of MGAT3 Substrates and Revelation of the Tumor-Suppressive Role of Bisecting GlcNAc in Breast Cancer via GLA Degradation
Bowen Wang, Xin He, Yue Zhou, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 103-103
Open Access
Regulation of PD-L1 glycosylation and advances in cancer immunotherapy
Te-An Lee, En-Yun Tsai, Shou-Hou Liu, et al.
Cancer Letters (2025), pp. 217498-217498
Closed Access
Glycoscience in Advancing PD-1/PD-L1-Axis-Targeted Tumor Immunotherapy
Qianqian Sun, Senlian Hong
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1238-1238
Open Access
Sonodynamic Activated Nanoparticles with Glut1 Inhibitor and Cystine-containing Polymer Stimulate Disulfidptosis for Improved Immunotherapy in Bladder Cancer
Ke Wang, Li Li, Ganghao Liang, et al.
Biomaterials (2025) Vol. 319, pp. 123178-123178
Closed Access
Crosstalk between O-GlcNAcylation and phosphorylation in metabolism: regulation and mechanism
Qijie Zhao, Siwei Zhou, Wenhui Lou, et al.
Cell Death and Differentiation (2025)
Closed Access
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy
Ravindra Pramod Deshpande, Kerui Wu, Shih-Ying Wu, et al.
EMBO Molecular Medicine (2025)
Open Access
Indole-3-Carbinol Inhibits PD-L1-Mediated Immune Evasion in Hepatocellular Carcinoma via Suppressing NF-κB p105 Ubiquitination
Yongkang Wu, Qing Tao, Jing Xie, et al.
Phytomedicine (2025), pp. 156692-156692
Closed Access
Page 1 - Next Page

Scroll to top